Olink Proteomics is a global organization that provides solutions and support for human protein biomarker discovery. The company is dedicated to innovation, quality, rigor, and transparency, and has grown rapidly from a small Sweden-based company offering assay for a few hundred proteins to a NASDAQ-listed organization with a strong global presence. Olink's mission is to accelerate proteomics with the scientific community to understand real-time biology and gain actionable insights into human health and disease, with the goal of developing better, more targeted therapies and revolutionizing future healthcare through the implementation of precision medicine. Ollink offers a broad portfolio of flexible protein biomarkers solutions and a library of high-quality, thoroughly validated assays that cover ~3000 proteins, with a focus on population-scale proteogenomics, biomarker detection to clinical utility, and proteomics in drug development. Olink Holding AB (publ) operates as a subsidiary of Thermo Fisher Scientific Inc.